Indian pharma stocks dropped sharply on September 26 after US President Donald Trump announced 100% tariffs on imported branded and patented medicines starting October 1. The move pressures companies to set up US-based production to avoid penalties. BulletsIn Nifty Pharma index fell 2.54% in early trade Sun Pharma down 5%, hit yearly low at ₹1,547












